USD
+$0.00
(+0.00%
)At Close (As of Sep 12, 2025)
$4.72M
Market Cap
-
P/E Ratio
-0.24
EPS
$1,200.00
52 Week High
$0.55
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | - |
Total Revenue | $0 |
Cost Of Revenue | $118K |
Costof Goods And Services Sold | $118K |
Operating Income | -$1.3M |
Selling General And Administrative | $768K |
Research And Development | $534K |
Operating Expenses | $1.3M |
Investment Income Net | - |
Net Interest Income | -$28K |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $118K |
Income Before Tax | -$1.5M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$1.5M |
Comprehensive Income Net Of Tax | - |
Ebit | -$1.5M |
Ebitda | -$1.4M |
Net Income | -$1.5M |
Field | Value (USD) |
---|---|
Total Assets | $5.5M |
Total Current Assets | $2.7M |
Cash And Cash Equivalents At Carrying Value | $2.6M |
Cash And Short Term Investments | $2.6M |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $2.9M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $2.9M |
Intangible Assets Excluding Goodwill | $2.9M |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $0 |
Other Current Assets | $99K |
Other Non Current Assets | - |
Total Liabilities | $261K |
Total Current Liabilities | $261K |
Current Accounts Payable | - |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | - |
Total Non Current Liabilities | $0 |
Capital Lease Obligations | - |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | - |
Other Current Liabilities | $261K |
Other Non Current Liabilities | - |
Total Shareholder Equity | $5.3M |
Treasury Stock | - |
Retained Earnings | -$5.1M |
Common Stock | - |
Common Stock Shares Outstanding | $3M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$1.1M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $118K |
Capital Expenditures | $0 |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | $29K |
Cashflow From Financing | $3.7M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$1.5M |
Field | Value (USD) |
---|---|
Gross Profit | - |
Total Revenue | $0 |
Cost Of Revenue | $118K |
Costof Goods And Services Sold | $118K |
Operating Income | -$1.3M |
Selling General And Administrative | $768K |
Research And Development | $534K |
Operating Expenses | $1.3M |
Investment Income Net | - |
Net Interest Income | -$28K |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $118K |
Income Before Tax | -$1.5M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$1.5M |
Comprehensive Income Net Of Tax | - |
Ebit | -$1.5M |
Ebitda | -$1.4M |
Net Income | -$1.5M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company is headquartered in Ra'anana, Israel.